More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

By Dr. Sanchari Sinha Dutta, Ph.D. New research uncovers how distinct molecular profiles and immune signatures in metastatic ...

This discovery opens up new perspectives for the development of targeted therapies. With one of the lowest survival rates, pancreatic cancer urgently requires solutions. The enzyme Mical2, involved in ...

The Paul-Ehrlich-Institute (PEI) in Germany has granted approval to continue subject enrolment in cohort 5 of Oncolytics ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

Oncolytics Biotech received approval from Germany\u2019s Paul-Ehrlich-Institute to advance Cohort 5 of the GOBLET study, ...

The American Cancer Society's annual cancer trend report shows cancer mortality is decreasing but cancer rates are increasing in young adults and women.

AI Innovation Unlocks Non-Surgical Way to Detect Brain Cancer Spread Jan. 14 ... Experimental Blood Test for Pancreatic Cancer Undergoing Clinical Development and Evaluation Jan.

Cancer incidence continues to rise for many common cancers—especially for women. The incidence rate for women younger than 50 ...

Today the American Cancer Society called out the need for more progress on pancreatic cancer, citing it as the third-leading cause of cancer-related death in the U.S. Their annual report also includes ...

Cancer diagnoses are expected to exceed two million in 2025, with approximately 618,120 deaths predicted, according to the ...